216 related articles for article (PubMed ID: 32981462)
1. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
Holder K; Reddy PH
Neuroscientist; 2021 Aug; 27(4):331-339. PubMed ID: 32981462
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19.
Roganović J
Med Hypotheses; 2021 Jan; 146():110448. PubMed ID: 33338955
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19.
Argano C; Mallaci Bocchio R; Lo Monaco M; Scibetta S; Natoli G; Cavezzi A; Troiani E; Corrao S
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270015
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.
Ganji R; Reddy PH
Front Aging Neurosci; 2020; 12():614650. PubMed ID: 33510633
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
6. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
7. Impact of Diabetes in Patients Diagnosed With COVID-19.
Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
Front Immunol; 2020; 11():576818. PubMed ID: 33335527
[TBL] [Abstract][Full Text] [Related]
8. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
9. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
Kumar V
Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
[TBL] [Abstract][Full Text] [Related]
10. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
Khwatenge CN; Pate M; Miller LC; Sang Y
Front Immunol; 2021; 12():732913. PubMed ID: 34737743
[TBL] [Abstract][Full Text] [Related]
11. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
[TBL] [Abstract][Full Text] [Related]
12. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
13. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
Pugazhenthi S; Qin L; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
[TBL] [Abstract][Full Text] [Related]
14. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
Weis N; Thorsteinsson K; Martinussen C; Madsbad S
Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
[TBL] [Abstract][Full Text] [Related]
15. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
16. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.
Drucker DJ
Cell Metab; 2021 Mar; 33(3):479-498. PubMed ID: 33529600
[TBL] [Abstract][Full Text] [Related]
19. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection.
Maggi P; Ricci E; Messina V; Salzillo A; Simeone F; Iodice A; Socio GV
Expert Rev Clin Immunol; 2021 Mar; 17(3):201-208. PubMed ID: 33538189
[TBL] [Abstract][Full Text] [Related]
20. Diabetes, obesity and COVID-19: A complex interplay.
Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
